P-100 Improvement in Quality of Life as a Predictor of Long-Term Remission in Crohnʼs Disease Patients Treated with Certolizumab Pegol

Authors :: Gordana Kosutic
Jason Coarse
William J. Sandborn
Iram Hasan
Stefan Schreiber
Marshall Spearman
Brian G. Feagan
Source :: Inflammatory Bowel Diseases. 22:S41
Publication Year :: 2016
Publisher :: Oxford University Press (OUP), 2016.

Subjects :: medicine.medical_specialty
Tumor necrosis factors
business.industry
Gastroenterology
Disease
medicine.disease
Inflammatory bowel disease
03 medical and health sciences
0302 clinical medicine
Quality of life
030220 oncology & carcinogenesis
Internal medicine
medicine
Immunology and Allergy
030211 gastroenterology & hepatology
Long term remission
Certolizumab pegol
business
medicine.drug

Full Text Access

Tools